Bloomberg, citing DealForma data, reports Western pharma firms spent $3.15 billion on Chinese drug molecules in 2024, a rare collaborative bright spot facing heightened scrutiny under Trump and the Biosecure Act. Check out Bloomberg’s report.
Bloomberg, citing DealForma data, reports Western pharma firms spent $3.15 billion on Chinese drug molecules in 2024, a rare collaborative bright spot facing heightened scrutiny under Trump and the Biosecure Act. Check out Bloomberg’s report.
DealForma is the biopharma deal database providing you comprehensive information and dedicated analyst support to help you be more confident using quality data in your business development research.
Database
Company
Comparisons
Website Design by Once Interactive
